Skip to main content
Clinical Trials/DRKS00011138
DRKS00011138
Completed
N/A

Hemodynamic and Clinical Monitoring Program During and After the MitraClip® Procedure in Patients with Secondary MR and Advanced Systolic Heart Failure - Mitraclip Conductance

niversitätsklinikum Magdeburg0 sites77 target enrollmentNovember 30, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
I50
Sponsor
niversitätsklinikum Magdeburg
Enrollment
77
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 30, 2016
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Magdeburg

Eligibility Criteria

Inclusion Criteria

  • Age \>18 years
  • \-Systolic heart failure, EF \< 25%, NYHA III/IV
  • \-Severe functional mitral regurgitation according to ACC/AHA guidelines: ERO \= 20 mm2, regurgitant fraction \= 50%, regurgitant volume \= 30ml
  • \-Clinical indication for MitraClip® Implantation
  • \-Cardiac index \= 2\.1 l/min/qm
  • \-Signed written informed consent

Exclusion Criteria

  • \-Myocardial infarction within the last 3 months
  • \-Consuming tumor with an expected life expectancy \< 12 months
  • \-Impossibility of MitraClip®\-Implantation
  • \-Inability to follow instructions or comply with follow\-up procedures, e.g. 6\-minute\-Walking Test
  • \-Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials